全神经内镜技术经眶上外侧入路切除鞍区肿瘤疗效分析  

Efficacy analysis of full-neuroendoscopic resection of sellar tumors via lateral supraorbital approach

作　　者：唐科[1] 蒋天伟[1] 陆军松[1] 夏为民[1] 邵耐远[1] 周鹏[1] TANG Ke;JIANG Tianwei;LU Junsong;XIA Weimin;SHAO Naiyuan;ZHOU Peng(Department of Neurosurgery,The Third Affiliated Hospital,Soochow University,Changzhou 213003,China)

机构地区：[1]常州市第一人民医院神经外科,常州213003

出　　处：《临床神经外科杂志》2025年第2期201-204,共4页Journal of Clinical Neurosurgery

基　　金：2024年常州市第十一批科技计划项目(CJ20245008);常州市卫健委重大科技项目(ZD202331)。

摘　　要：目的 总结全神经内镜技术经眶上外侧入路治疗鞍区肿瘤的临床疗效。方法 回顾性分析2020年1月—2023年6月常州市第一人民医院神经外科收治的18例鞍区肿瘤患者的临床资料。所有患者均通过全神经内镜技术经眶上外侧入路切除肿瘤,术后随访12~36个月,复查头颅磁共振。结果 15例(83.3%)肿瘤全切,3例(16.7%)次全切。术后新发垂体功能低下2例,一过性尿崩及水电解质紊乱3例,1例出现额叶挫伤,1例颅内感染。术后随访12~36个月,未见肿瘤复发,残留肿瘤无进展。结论 全神经内镜下经眶上外侧入路切除鞍区肿瘤安全有效。Objective To summarize the clinical effect of full-neuroendoscopic trans-lateral supraorbital approach in the treatment of sellar tumors.Methods The clinical data of 18 patients with sellar tumors admitted to the Department of Neurosurgery,the First People's Hospital of Changzhou from January 2020 to June 2023 were analyzed retrospectively.All patients underwent full-neuroendoscope to remove tumors through trans-lateral supraorbital approach,and were followed up for 12 to 36 months after surgery,with follow-up of head magnetic resonance imaging.Results Total resection was achieved in 15 cases(83.3%) and subtotal resection in 3 cases(16.7%).Postoperative hypopituitarism occurred in 2 cases,transient diabetes insipidus and water-electrolyte disturbance in 3 cases,frontal lobe contusion in 1 case and intracranial infection in 1 case.After 12-36 months follow-up,there was no recurrence of tumor and no progress of residual tumor.Conclusions It is safe and effective to remove sellar tumors through trans-lateral supraorbital approach by full-neuroendoscope.

关 键 词：神经内镜手术 眶上外侧入路 显微外科手术 鞍区肿瘤 

分 类 号：R651[医药卫生—外科学] R739.41[医药卫生—临床医学]